This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lokeshwar, B. L. Articles by Block, N. L. Search for Related Content PubMed PubMed Citation Articles by Lokeshwar, B. L. Articles by Block, N. L.

Human Prostatic Inhibin Suppresses Tumor Growth and Inhibits Clonogenic Cell Survival of a Model Prostatic Adenocarcinoma, the Dunning R3327G Rat Tumor¹

Department of Urology [B. L. L., N. L. B.] and Oncology [N. L. B.], School of Medicine, University of Miami, Miami, Florida; and Institute for Research in Reproduction (ICMR), Parel, Bombay, India [K. S. H., A. R. S.]

Prostatic inhibin (PI) is a M_r 10,700 protein found in human seminal plasma and is secreted by the prostate. Recognition of alteration of PI levels in prostatic diseases prompted us to investigate its effect on an animal prostatic adenocarcinoma model, the Dunning R3327G rat tumor. PI not only inhibited in vitro growth of tumor cells but also suppressed tumor growth in vivo. A dose- dependent inhibition of both the clonogenic cell growth and rate of proliferation (DNA synthesis) was observed in tumor cell cultures incubated with purified PI. These inhibitory activities were similar in both androgen-dependent and androgen-independent Dunning tumor cell lines. A functional decapeptide of PI was also found to inhibit Dunning tumor cell colonies in a dose-dependent manner. Daily injection of purified PI into tumor-bearing rats suppressed the tumor growth. A 58% reduction in tumor weight and a 2-fold reduction in tumor growth rate were observed over a 15-day treatment period. Continued treatment with PI significantly suppressed the tumor growth rate by nearly 3-fold. These findings clearly demonstrate a potential application of PI for treating human prostatic adenocarcinoma.

¹ This work was supported in part by the Sylvester Comprehensive Cancer Center, the Weeks Endowment Fund, Department of Urology, University of Miami, Miami, Florida, and the Indian Council for Medical Research, India.

² To whom requests for reprints should be addressed, at Department of Urology (M-800), University of Miami School of Medicine, P.O. Box 016960, Miami, FL 33101.

Received 5/29/92. Accepted 8/10/93.

This article has been cited by other articles:

				C. Valtonen-Andre, C. Savblom, P. Fernlund, H. Lilja, A. Giwercman, and A. Lundwall Beta-Microseminoprotein in Serum Correlates With the Levels in Seminal Plasma of Young, Healthy Males J Androl, May 1, 2008; 29(3): 330 - 337. [Abstract] [Full Text] [PDF]